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Abstract: The aim of the article was to review phytosterols as functional food and its significance in lowering choles-
terol as well as its specific effect on human health. Phytosterols has been known for its cholesterol lowering action 
long time back but the uprising of phytosterols in form of functional foods gained the interest once again. Fatty food 
matrix provides optimal solubility but fortification of phytosterols with other food matrices like low fat fermented milk, 
bread, juice are showing positive results. A dose of 2 g/day of either steryl or stanyl esters has been prescribed for 
an optimum effect which has been confirmed by FDA and EC. A number of studies have documented the safety and 
the efficiency of phytosterols. But there is still a big question mark on the use of it because of their adverse effect on 
body in form of Phytosterol oxidation products (POPs). It needs further investigation to elucidate effect of POPs 
within body.       
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INTRODUCTION 
Plant sterols are nonnutritive compounds (or phyto-
chemicals) which regulate the membrane fluidity of 
plant cells (Brufaua et al., 2008; Kritchevskya and 
Chen, 2005).  The same function, cholesterol does in 
animals. Plant sterols include sterols and stanols and 
these are called phytosterols and phytostanols respec-
tively but combinedly and generally they are called 
phytosterols. Structurally, both phytosterols and cho-
lesterol have same sterol ring but the difference is in 
the side chain (Jong et al., 2003; Fernandes and 
Cabral, 2007; Cantrill and Kawamura, 2008) Phytos-
terols have additional alkyl subtituents at C-24 and/or a 
double bond at C-22. More than 200 phytosterols (PS) 
have been identified in which ß-sitosterol (65%), 
campesterol (32%), and stigmasterol (3%) are most 
abundant (Vanmierlo et al., 2013). Ergosterol is mostly 
found in fungal cell. In plant tissues, PS occur in five 
common forms: free sterols, fatty-acid esters (steryl 
ester), steryl glycosides, acylated steryl glycosides, and 
hydroxycinnamic acid steryl esters (Moreau et al., 
2002). Stanols do not have double bonds in the sterol 
ring and are called saturated sterols (Moreau et al., 
2002.). Stanols are less abundant in nature than sterols. 
Main stanols are campestanol and sitostanol. Plant 
stanols are also produced by hydrogenating sterols 
(Chen et al., 2013). These phytosterols are normal con-
stituents of the human diet. 
Absorption and metabolism of phytosterols: Choles-
terol absorption in humans varies from 30% to 60% 
but absorption of PS is rather low (Salen et al., 1989; 
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Miettinen et al., 1990; Ling and Jones, 1995; Garcia-
Llatasa and Rodriguez-Estradab, 2011). Absorption 
levels for campesterol (9.4–14.8%) are approximately 
3 times higher than for ß-sitosterol (3.1–4.5%) and 
stigmasterol (∼4%). Absorption of campestanol and 
sitostanol has varies (0.1–2%) (Heinemann et al. 1993; 
Miettinen et al., 2000, Piironen et al., 2000; Sanders et 
al., 2000). The reason behind more cholesterol absorp-
tion is the presence of a double bond between C-5 and 
C-6 which increases the absorption rate. But in phytos-
terols, the Increase in the side chain length decreases 
its absorption. Phytostanols do not have double bond 
in sterol ring, which decreases the rate of absorption in 
body. 
Mechanism of action of phytosterols: Phytosterols 
decrease absorption of cholesterol from diet which 
leads to suppressed feedback-regulation of entero-
hepatic cholesterol in circulation, resulting in increased 
production of cholesterol within body increasing the 
endogenous cholesterol synthesis. The absorbed phy-
tosterols decrease the synthesis of cholesterol in body 
(Eisenberg, 2003; Shin et al., 2005; Micallef and Garg, 
2008; Malinowski and Gehret, 2010). This way PS 
decreases both exogenous and endogenous production 
of cholesterol (Berge et al., 2000; Brufaua et al., 
2008). The mechanism of cholesterol lowering action 
of phytosterols can be easily understood by the follow-
ing ways: 
Inhibition of cholesterol cbsorption in intestine: 
There is solubilization competition between choles-
terol and PS in dietary mixed micelles (Wu et al., 
2009; Gupta et al., 2011), in order to pass through the 
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intestinal cells and to be absorbed into the blood-
stream. Since cholesterol is only marginally soluble in 
these micelles and it is displaced by phytosterols (Plat 
and Mensink, 2005; Micallef and Garg, 2009). This is 
done by two ways: 
There is competition for esterase activity between cho-
lesterol and PS, leading to a reduction of cholesterol in 
its absorbable form or its transport to more distal parts 
of the intestine where absorption is less efficient 
(Brufaua et al., 2008). 
There is competition for cholesterol transporters, such 
as the NPC1L1, between cholesterol and PS in the 
intestinal brush border membrane (Davis et al., 2004; 
Bergmann et al., 2005; Jakulj et al., 2005). Since PS 
and cholesterol structures are very similar (Otaegui-
Arrazola et al, 2010), PS may be transported into the 
enterocyte, instead of cholesterol, thus reducing the 
uptake of cholesterol (Brufaua et al., 2008). 
Synthesis and excretion of cholesterol: Intestinal 
ACAT re-esterifies the absorbed cholesterol in the 
mucosal cell. Since esterification of PS occurs in slow 
pace than that of cholesterol which encourages sup-
pressed activity of ACAT and reduces cholesterol up-
take (Rodwell et al., 1976). 
About 70–80% of the transported cholesterol is esteri-
fied, so it is possible that the incorporation into chy-
lomicrones mainly depends on the esterification step 
(Ikeda et al., 1988). There is competition between cho-
lesterol and PS for the incorporation into chylomi-
crones. Since PS is esterified in a minor degree than 
cholesterol, thus, lowers the cholesterol level. 
ABC transporters play a role in absorption of PS and 
cholesterol into mucosal cells. ABCG5 and ABCG8 
are responsible for efflux of absorbed phytosterols and 
cholesterol back into intestinal lumen from entero-
cytes. From intestinal lumen, they are sent to large 
intestine where hydrolysis of cholesterol and phytos-
terols takes place (Berge et al., 2000). 
Food sources: Nuts and vegetable oils can contain 
more than 1% of phytosterols. On the other hand, phy-
tostanols occur in certain cereals (corn, wheat, rye, and 
rice), fruits and vegetables, but their concentrations are 
much lower than those of unsaturated PS. Oil and fat 
refining processes lead to a loss of PS (mainly free 
ones), which can vary from 10% to 70% depending on 
the applied conditions. PS are natural components of 
human diets (Weihrauch and Gardner, 1978; Phillips et 
al., 2005). An average daily intake of PS from natural 
sources is estimated between 150 and 440mg in West-
ern countries (Ostlund, 2002; Jimenez-Escrig et al., 
2006) 
Need of fortification:  Phytosterols has been known 
for its cholesterol lowering action since 1950s (Russel 
et al., 2002; Demonty et al., 2006; Ortega et al., 2006; 
Acuff et al., 2007; Earnest et al. 2007; Marangoni and 
Poli, 2010; Rocette et al., 2010). ß-sitosterol had been 
used as a supplement and as a drug to lower serum 
cholesterol for a long time. But phytosterols extracted 
from oil is insoluble in water, relatively insoluble in oil 
and soluble in alcohol. So, due to its Poor solubility 
and bioavailability, serum cholesterol lowering effects 
were not always consistent and high doses and some-
times very High doses (up to 25–50 g per day) were 
required to show cholesterol lowering effect. After 
introducing effective anti-cholesterolemic drugs like 
statin, the use of ß-sitosterol vanished (Pollak, 1953). 
But In 1990s, it regained interest as an idea of func-
tional foods (Jones and Abumweis, 2009). An accurate 
PS solubilization in the food vehicle is important for 
the best possible action on lipid serum levels. Foods 
provide a vehicle (matrix) to PS to be absorbed more 
efficiently. Various matrices, including fatty foods, 
low fat foods and non-fat food have been used. Fatty 
food matrix provides optimal solubility of added com-
pounds. 
Safety level and frequency of consumption: Govern-
ment agencies, such as the FDA and in EC has con-
firmed about the safety level of PS. It is considered 
that a dose of 2 g/day of either steryl or stanyl esters 
should give an optimum effect (Berger et al., 2004; 
Jong et al., 2007; Naumann et al., 2008). 5–15% and 
10-20% reduction in total cholesterol and LDL levels 
respectively can be expected by consuming 1.5–3 g of 
phytosterols or stanols (Nguyen, 1999; Tikkanen, M.J., 
2005).  Katan et al. (2003) reported that PS have to be 
present in the lumen for interference with cholesterol 
uptake which provided evidence of phytostanol’s inde-
pendence upon number of meals (Matvienko et al., 
2002; Wolfs et al., 2006; Madsen et al., 2007; Clifton 
et al., 2008) and doses per day (Rozner and Garti, 
2006). So PS showed a long-lasting cholesterol lower-
ing effect on its metabolism. 
Phytostanols vs. phytosterols: No significant differ-
ence in the serum lipids reducing properties of both 
sterols and stanols was found when comparable studies 
were conducted (Jones et al., 2000; Normen et al., 
2000; Noakes et al., 2002),  The effects of sterols and 
stanols esters are also relatively equivalent (Law, 
2000, Talati et al., 2010). No-observed-adverse-effect 
Ergosterol
Stigmasterol
Cholesterol
Fig 1. Structures of different sterols (Cantrill and Kawamura, 
2008 (modified); Lavova et al., 2013, (modified). 
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level (NOAEL) was established at highest applied dose 
of 6 g/kg body weight/day of plant sterols esters.  
Effect of phytosterols on different parameters: 
On fat-soluble  vitamins: Antioxidants studies, have 
shown that daily consumption of 3.8 to 4.0 g plant 
stanols provided as fatty acid esters during a period of 
eight weeks significantly lowers serum concentrations 
of various cartenoids and tocopherols (Plat and Men-
sink, 2001). Plasma retinol (vitamin A) and vitamin D 
concentrations were not affected because the absorp-
tion or synthesis of these fat-soluble vitamins, are not 
transported by lipoproteins. 
On vitamin K concentrations: Effect on vitamin K 
concentration is not clear. Eight weeks of 3.8 g vegeta-
ble oil based plant stanols or 4.0 g wood based plant 
stanols had no effect on vitamin K dependent blood 
coagulation factors and fibrinolytic parameters 
(Nguyen and Dale, 1999). Study of Hendriks et al. 
(2003) contradicts the above results. 
On colon and prostate cancer: There is no strong and 
consistent evidence that sitosterol intake affects either 
colon or prostate cancer. (Kennedy, 1995, Klippel et 
al., 1997) but Woyengo et al. (2009) reported the in-
hibitory action of phytosterols on lung, stomach and 
ovarian cancer. 
On membrane properties: Plant sterols and stanols 
are incorporated into cellular membranes (Child and 
Kuksis, 1982) and may consequently influence mem-
brane properties. Although one of the studies (Mora et 
al., 1999) showed no effects of sitosterol on the mem-
brane fluidity, it has been suggested that plant sterols 
can incorporate in red blood cell membranes, replacing 
cholesterol, which made the erythrocytes less deform-
able and more fragile (Bruckerdorfer et al., 1969). 
On the immune system: Effects of plant sterols and 
stanols on immune function have not been studied in 
detail, but some studies do suggest that these com-
pounds may have an effect. For example, plant sterol 
supplementation lowered serum interleukin-6 (IL-6) 
concentrations which assisted in lowering inflamma-
tory response (Bouic et al., 1999). 
Sitosterolemia: It is a rare autosomal recessive disor-
der, with mutations in the ABCG5 or ABCG8 genes. 
In which there is Excessive accumulation of stanols/
sterols in body because of reduced ability of liver to 
excrete plant sterols which is known to be associated 
with premature coronary artery disease tendon, tuber-
ous xanthomas (Salen et al., 1992) and death. 
POPs: Phytosterols are susceptible to oxidation like 
cholesterol because of their inherent and close molecu-
lar structure to cholesterol (Yvonne et al., 2014). They 
form hydroxy, epoxy, keto and triol derivatives which 
are collectively known as Phytosterol Oxidation Prod-
ucts (POPs). It may be enzymatic or non-enzymatic 
(Ryan et al, 2009). 
Non-enzymatic oxidation: Sterol autoxidation is oxi-
dation of the steroid nucleus through storage, process-
ing and preparation of foodstuffs which is called non-
enzymatic oxidation. 
Enzymatic oxidation: it is conversion of phytosterols 
to their oxides on application of enzymes vivo. Forma-
tion of cholesterol oxidation products (COP) is the 
result of enzymatic activity of the intestinal microflora 
(Hwang and Kelsey 1978). It may possible with the PS 
also, encouraging POP formation in vivo. 
Four individual phytosterol oxides are: 7-ketocampesterol, 7-
keto-b-sitosterol, 7-b-OH-campesterol and 7-b-OH-b-
sitosterol. 
Effect of POP on cholesterol uptake and its metabo-
lism and other body organs is still to be uncovered. It 
requires future investigation to elucidate their specific 
effects on human health and to reduce their production 
in foods and in vivo.  
Food Source Phytosterol (mg/100g) 
Cereals   
Wheat bran 200 
Wheat germ 345.6 
Fruits and vegetable   
Banana 16 
Beet 25 
Broccoli 49.4 
Cabbage 11.4 
Carrot 15.3 
Cauliflowers 18 
Figs 31 
Lettuce 39 
Oranges 24 
Soyabeans 48.3 
Oils and fats   
Almond oil 265 
Canola oil 657 
Corn oil 909 
Olive oil 157 
Walnut oil 176.5 
Wheat germ oil 555.56 
Nuts and seeds   
Almonds 137.5 
Flax seed 210 
Peanut 221 
Pistachio nuts 214 
Sesame seeds 714 
Walnut 113 
Fortified Foods Phytosterol  
(g/100g or ml) 
Orange Juice 0.68 
Pasta (Finland) 2.43 
Snack Bar 6.8 
Spread 11.33 
Yogurt drinks (Ecuador) 2.83 
Table 1. Sources of phytosterols. 
(Piironen and Toivo, 2003, Chen and Blumberg, 2008; Cantrill 
and Kawamura, 2008; USDA, 2011 (US Department of Agri-
culture) National Nutrient Database Release) 
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Conclusion     
Earlier, the use of phytosterols were limited as drugs 
for lowering cholesterol, later, it was fortified with fat 
matrix but now positive results have been reported for 
phytosterols as functional foods in other matrices 
also.many fortified products including spread, orange 
juice, pasta, yogurt, snack bars and milk drinks are 
available in market. No adverse effect of risk associ-
ated with decreased level of fat soluble vitamins like 
carotene and tocopherol was seen on consumption of 
phytosterols. No teratogenic effect and no toxicity 
were reported. So it might be a better option for pa-
tients who have fear of intolerance, side effects and 
cost of medicines. Natural and available form of phy-
tosterols should be preferred for consumption. Fortifi-
cation of PS in non-fat food should be encouraged. 
Research should be done for effectiveness of PS for 
general population. Role of phytosterols on colon, ves-
sel wall and other organs is not clear. So researches are 
needed in this area to discover its role on colon cancer 
as many contradictory studies have been reported.  
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